Welcome to CDC stacks | A Multi-Targeted Drug Delivery Vehicle Approach that Targets, Triggers, and Thermally Ablates HER2+ Breast Cancer Cells** - 47323 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
A Multi-Targeted Drug Delivery Vehicle Approach that Targets, Triggers, and Thermally Ablates HER2+ Breast Cancer Cells**
Filetype[PDF-571.78 KB]


No Related Documents.
You May Also Like:
  1. Enhanced HER2 Degradation in Breast Cancer Cells by Lysosome-Targeting Gold Nanoconstructs
    Personal Author:
    Lee, Hyojin; Dam, Duncan Hieu M.; Ha, Ji Won; Yue, Jun; Odom, Teri W.;
    Published:
    Sep 03 2015
    Source:
    ACS Nano. 9(10):9859-9867.
    Description:
    This paper describes how gold nanoparticle nanoconstructs can enhance anticancer effects of lysosomal targeting aptamers in breast cancer cells. Nanoconstructs consisting of anti-HER2 aptamer (human epidermal growth factor receptor 2, HApt) densely g...
    File Type:
    Filetype[PDF - 1.73 MB]
  2. A Functional Landscape of Resistance to ALK Inhibition in Lung Cancer
    Personal Author:
    Wilson, Frederick H.; Johannessen, Cory M.; Piccioni, Federica; Tamayo, Pablo; Kim, Jong Wook; Van Allen, Eliezer M.; Corsello, Steven M.; Capelletti, Marzia; Calles, Antonio; Butaney, Mohit; Sharifnia, Tanaz; Gabriel, Stacey B.; Mesirov, Jill P.; Hahn, William C.; Engelman, Jeffrey A.; Meyerson, Matthew; Root, David E.; Jänne, Pasi A.; Garraway, Levi A.;
    Published:
    Mar 9 2015
    Source:
    Cancer Cell. 2015; 27(3):397-408.
    Description:
    We conducted a large-scale functional genetic study to characterize mechanisms of resistance to ALK inhibition in ALK-dependent lung cancer cells. We identify members of known resistance pathways and additional putative resistance drivers. Among the ...
    File Type:
    Filetype[PDF - 2.41 MB]
  3. Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy
    Personal Author:
    Lohcharoenkal, Warangkana; Wang, Liying; Chen, Yi Charlie; Rojanasakul, Yon;
    Published:
    Mar 20 2014
    Source:
    Biomed Res Int. 2014; 2014.
    Description:
    Nanoparticles have increasingly been used for a variety of applications, most notably for the delivery of therapeutic and diagnostic agents. A large number of nanoparticle drug delivery systems have been developed for cancer treatment and various mat...
    File Type:
    Filetype[PDF - 890.84 KB]
  4. Opportunities for translational epidemiology: The important role of observational studies to advance precision oncology
    Personal Author:
    Marrone, Michael; Schilsky, Richard L.; Liu, Geoff; Khoury, Muin J.; Freedman, Andrew N;
    Published:
    Mar 2015
    Source:
    Cancer Epidemiol Biomarkers Prev. 24(3):484-489
    Description:
    Within current oncology practice, several genomic applications are being used to inform treatment decisions with molecularly targeted therapies in breast, lung, colorectal, melanoma, and other cancers. This commentary introduces a conceptual framewor...
    File Type:
    Filetype[PDF - 273.44 KB]
  5. Wnt signaling in triple negative breast cancer is associated with metastasis
    Personal Author:
    Dey, Nandini; Barwick, Benjamin G; Moreno, Carlos S; Ordanic-Kodani, Maja; Chen, Zhengjia; Oprea-Ilies, Gabriella; Tang, Weining; Catzavelos, Charles; Kerstann, Kimberly F; Sledge, George W; Abramovitz, Mark; Bouzyk, Mark; De, Pradip; Leyland-Jones, Brian R;
    Published:
    Nov 10 2013
    Source:
    BMC Cancer. 2013; 13:537.
    Description:
    Background : Triple Negative subset of (TN) Breast Cancers (BC), a close associate of the basal-like subtype (with limited discordance) is an aggressive form of the disease which convey unpredictable, and poor prognosis due to limited treatment optio...
    File Type:
    Filetype[PDF - 1.82 MB]